Serum and plasma as alternative sample types in analysis of cardiac markers in the clinical routine

REFERENCES

• Milller-Bardoff M, Freitag H, Scheffold T, Remppis A, Kibler W, Katus HA. Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. Circulation 1995; 92: 2869–75.
   Google Scholar
• Collison PO, Gerhardt W, Katus HA, Milner-Bardorff M, Braun S, Schricke U, Vogt W, Nagel D, Zander M, Leinberger R, Mangold D, Zerback R. Multicenter evaluation of an immunological rapid test for detection of troponin T in whole blood samples. Eur J Clin Chem Clin Biochem 1996; 34: 591–8.
   Google Scholar
• Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Bergen J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997; 337: 1648–53.
   PubMed Web of Science ®Google Scholar
• Penttild K, Koukkunen H, Kemppainen A, Halinen M, Rantanen T, Pyörälä K, Penttild I. Myoglobin, creatine kinase MB, troponin T and troponin I rapid bedside assays in patients with acute chest pain. Int J Clin Lab Res 1999; 29: 93–101.
   Google Scholar
• Milller-Bardorff M, Sylvén C, Rasmanis G, Jorgensen B, Collison PO, Waldenhofer U, Hirschl MM, Laggner AN, Gerhardt W, Hafner G, Labaere I, Leinberger R, Zerback R, Katus KA. Evaluation of a point-of-care system for quantitative determination of troponin T and myoglobin. Clin Chem Lab Med 2000; 38: 567 —74.
   PubMedGoogle Scholar
• Wu AHB, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Waldes R Jr. National Academy of Biochemistry Standards of Laboratory Practice: Recommendations for the use of cardiac markers in coronary heart diseases. Clin Chem 1999; 45: 1104–21.
   Google Scholar
• Gerhardt W, Nordin G, Herbert A-K, Burzell BL, Isaksson A, Gustavsson E, Haglund S, Muller-Bardorff M, Katus HA. Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury. Clin Chem 2000; 46: 817–21.
   Google Scholar
• Stiegler H, Fischer Y, Vazquez-Jimenez JF, Graf J, Filzmaier K, Fausten B, Janssens U, Gressner AM, Kunz D. Lower cardiac troponin T and I results in heparin-plasma than in serum. Clin Chem 2000; 46: 1338–44.
   Google Scholar
• Wu AHB, Feng Y-J, Moore R, Apple FS, McPherson PH, Buechler KF, Borod G. Charac-terization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem 1998; 44: 1198–208.
   Google Scholar
• Thygesen K, Alpert JS. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959–69.
   PubMedGoogle Scholar
• Antman EM, Grudzien C, Sacks DB. Evaluation of a rapid bedside assay for detection of serum cardiac troponin T. JAMA 1995; 273: 1279–82.
   Google Scholar
• Penttild K, Penttild I, Bonnell R, Kerth P, Koukkunen H, Rantanen T, Pyörälä K. Comparison of the troponin T and troponin I ELISA tests, as measured by microplate immunoassay techniques, in diagnosing acute myocardial infarction. Eur J Clin Chem Clin Biochem 1997; 35: 767–74.
   Google Scholar
• Hallenmayer K, Klenner D, Vogel R. Use of recombinant human cardiac troponin T for standard-ization of third generation troponin T methods. Scand J Clin Lab Invest 1999; Suppl 230: 128–31.
   Google Scholar
• Poirey S, Polge A, Bertinchant JP, Bancel E, Boyer JC, Fabbro-Peray P, de Bornier BM, Ledermann B, Bonnier M, Bali JP. CKMB mass test in ischemic myocardial injury. Comparison of two tests: BioMerieux Vidas and sanofi access immunoassays. J Clin Lab Anal 2000; 14: 43–7.
   Google Scholar
• Zaninotto M, Pagani F, Altinier S, Ambroni P, Bonora R, Dolci A, Pergolini P, Vernocchi A, Plebani M, Panteghini M. Multicenter evaluation of five assays for myoglobin determination. Clin Chem 2000; 46: 163 1–7.
   Google Scholar
• Venge P, Lindahl B, Wallentin L. New generation cardiac troponin I immunoassay for the Access immunoassay system. Clin Chem 2001; 47: 959–61.
   Google Scholar
• Lestin M, Hergert M, Lestin H-G, Brinker C, Storm H, Kuhrt E, Kuhrt B, Lambrect H-G, Kiihnel W. Evaluation of the chemiluminescence immunoassays for the measurement of troponin I, myoglobin and CK-MB using the IMMULITE system in comparison to other measuring systems. Clin Lab 2002; 48: 211–21.
   Google Scholar
• Peetz D, Hafner G, Lackner KJ. Analytical Characteristics of the AxSYM cardiac troponin I and creatine kinse MB assays. Clin Chem 2002; 48: 1110–11.
   Google Scholar
• Penttild I, Pentfild K, Rantanen T. Laboratory diagnostics of patients with chest pain. Clin Chem Lab Med 2000; 38: 187–97.
   PubMedGoogle Scholar
• Norusis M SPSS/PC + statistics 4.0 for the IBM PC/XT/AT and PC/2. SPSS Inc., Chicago, USA, 1990.
   Google Scholar
• Koukkunen H, Penttild K, Kemppainen A, Halinen M, Penttild I, Rantanen T, Pyörälä K. Comparison of troponin T and creatine kinase MB isoenzyme mass with traditional enzyme activities in the diagnosis of myocardial infarction. Ann Med 1998; 30: 488–96.
   Google Scholar
• Panteghini M. IFCC Committee on Standard-ization of Markers of Cardiac Damage: premises and project presentation. International Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med 1998; 36: 887–93.
   PubMedGoogle Scholar
• Heeschen C, Goldmann BU, Langenbrink L, Matschuck G, Hamm CW. Evaluation of a rapid whole blood ELISA for quantification of troponin I in patients with acute chest pain. Clin Chem 1999; 45: 1789–96.
   Google Scholar
• Apple FS, Chistenson RH, Valdes R Jr, Andriak AJ, Berg A, Duh SH, Feng YJ, Jortani SA, Johnson NA, Koplen B, Mascotti K, Wu AH. Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. Clin Chem 1999; 45: 199–205.
   PubMed Web of Science ®Google Scholar
• AxSYM system, CK-MB, 68-1283/R4, Abbott Laboratories, Diagnostic Division, Abbott Park, Ii., USA, January 1997.
   Google Scholar
• Panteghini M, Apple FS, Christenson RH, Dati F, Mair J, Wu AH. Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes. Scand J Clin Lab Invest Suppl 1999; 230: 103–12.
   PubMedGoogle Scholar
• Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, O'Hanesian MA, Wagner GS, Kleiman NS, Harrell FE, Califf RM, Topol EJ. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO HA Investigators. N Engl J Med 1996; 31: 1333–41.
   Google Scholar
• Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease. N Engl J Med 2000; 343: 1139–47.
   Google Scholar
• Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, Fung AY, Thommson C, Wyberga D, Braunwald E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 1342 —49.
   Google Scholar